Xiangning Fu

3.8k total citations
132 papers, 2.3k citations indexed

About

Xiangning Fu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Xiangning Fu has authored 132 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 27 papers in Surgery. Recurrent topics in Xiangning Fu's work include Lung Cancer Diagnosis and Treatment (48 papers), Lung Cancer Treatments and Mutations (26 papers) and Tracheal and airway disorders (20 papers). Xiangning Fu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (48 papers), Lung Cancer Treatments and Mutations (26 papers) and Tracheal and airway disorders (20 papers). Xiangning Fu collaborates with scholars based in China, United States and Philippines. Xiangning Fu's co-authors include Ping Wei, Lequn Li, Wei Sun, Yixin Cai, Yu Deng, Yukun Zu, Yi Gao, Shengling Fu, Ni Zhang and Ni Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Xiangning Fu

122 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangning Fu China 27 828 775 593 569 279 132 2.3k
Da Xu China 24 839 1.0× 401 0.5× 609 1.0× 592 1.0× 279 1.0× 71 2.1k
Fang Wu China 23 689 0.8× 428 0.6× 467 0.8× 346 0.6× 154 0.6× 112 1.9k
Bin Sun China 31 1.1k 1.4× 418 0.5× 707 1.2× 729 1.3× 299 1.1× 94 3.0k
Timothy Craig Allen United States 26 669 0.8× 1.1k 1.5× 434 0.7× 369 0.6× 244 0.9× 90 2.5k
Diana N. Ionescu Canada 26 625 0.8× 1.1k 1.5× 893 1.5× 466 0.8× 304 1.1× 78 2.7k
Rosana Eisenberg United States 23 899 1.1× 790 1.0× 517 0.9× 733 1.3× 173 0.6× 43 2.1k
Daniela Terracciano Italy 37 1.1k 1.3× 1.2k 1.6× 451 0.8× 728 1.3× 381 1.4× 134 3.1k
David Chang United States 25 1000 1.2× 415 0.5× 1.4k 2.4× 385 0.7× 465 1.7× 68 2.9k
Ali S. Alzahrani Saudi Arabia 33 1.3k 1.6× 315 0.4× 618 1.0× 585 1.0× 567 2.0× 155 3.4k
Wenjian Yang United States 38 1.9k 2.3× 387 0.5× 913 1.5× 427 0.8× 256 0.9× 114 5.5k

Countries citing papers authored by Xiangning Fu

Since Specialization
Citations

This map shows the geographic impact of Xiangning Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangning Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangning Fu more than expected).

Fields of papers citing papers by Xiangning Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangning Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangning Fu. The network helps show where Xiangning Fu may publish in the future.

Co-authorship network of co-authors of Xiangning Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangning Fu. A scholar is included among the top collaborators of Xiangning Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangning Fu. Xiangning Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Xu, Yu Xi, Shaojie Hu, et al.. (2025). Targeting PD-1 and CD85j can restore intratumoral CD4+ GzmB+ T-cell functions to combat MHC-II-expressing tumors. Journal for ImmunoTherapy of Cancer. 13(4). e010890–e010890. 1 indexed citations
3.
4.
Hu, Shaojie, Baoyi Wang, Yu Xi, et al.. (2024). Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy. Biomarker Research. 12(1). 40–40. 2 indexed citations
5.
Wang, Qi, Kai Wang, Qing Zhou, et al.. (2024). Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk. International Journal of Nanomedicine. Volume 19. 1827–1842. 7 indexed citations
6.
Sun, Daqiang, Jian Hu, Xiaofei Li, et al.. (2023). Real-world surgical treatment patterns and clinical outcomes in patients with stages IA–IIIA non-small cell lung cancer: a retrospective multicentric observational study involving 11,958 patients. Journal of Cancer Research and Clinical Oncology. 149(11). 8213–8223. 2 indexed citations
7.
8.
Wu, Xi, Guoliang Li, Xiong Peng, et al.. (2023). Treatment and survival analysis for 40-year SEER data on upper esophageal cancer. Frontiers in Medicine. 10. 1128766–1128766. 1 indexed citations
9.
Wang, Baoyi, Shaojie Hu, Xiangning Fu, & Lequn Li. (2022). CD4+ Cytotoxic T Lymphocytes in Cancer Immunity and Immunotherapy. Advanced Biology. 7(4). e2200169–e2200169. 14 indexed citations
10.
Wang, Xue, Bing Huang, Rong Liu, et al.. (2021). An IFNγ/STAT1/JMJD3 Axis Induces ZEB1 Expression and Promotes Aggressiveness in Lung Adenocarcinoma. Molecular Cancer Research. 19(7). 1234–1246. 8 indexed citations
11.
Fang, Can, Weng Tao, Shaojie Hu, et al.. (2021). IFN-γ-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells. OncoImmunology. 10(1). 1962591–1962591. 78 indexed citations
12.
Gao, Yi, et al.. (2020). IL-10 suppresses IFN-γ-mediated signaling in lung adenocarcinoma. Clinical and Experimental Medicine. 20(3). 449–459. 11 indexed citations
13.
Huang, Bing, Rong Liu, Hui Xiong, et al.. (2020). CD8+CD57+ T cells exhibit distinct features in human non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 8(1). e000639–e000639. 35 indexed citations
14.
Wang, Qi, Yi Gao, Yixin Cai, et al.. (2020). Prevention and treatment of cross infection of novel coronavirus pneumonia in thoracic surgery ward. 371–375. 4 indexed citations
15.
Peng, Shu, Liu Huang, Bo Zhao, et al.. (2020). Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis. Journal of Thoracic and Cardiovascular Surgery. 160(2). 585–592.e2. 42 indexed citations
16.
Cai, Yixin, Yi Gao, Ping Wei, et al.. (2020). Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People’s Republic of China. Journal of Thoracic Oncology. 15(6). 1065–1072. 74 indexed citations
17.
18.
Zhang, Ni, Qinzi Xu, Yixin Cai, Shengling Fu, & Xiangning Fu. (2013). Operation mode and evolution of full thoracoscopic esophagectomy in treatment of esophageal carcinoma. 29(6). 323–325. 1 indexed citations
19.
Cai, Yixin, Xiangning Fu, Qinzi Xu, Wei Sun, & Ni Zhang. (2013). Thoracoscopic Lobectomy versus Open Lobectomy in Stage I Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS ONE. 8(12). e82366–e82366. 45 indexed citations
20.
Fu, Xiangning. (2009). The level of insulin-like growth factor-I in blood circulation in patients with non-small cell lung cancer after surgery and its clinical significance. Zhongguo aizheng zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Da Xu Breakdown of academic impact, for papers by Fang Wu Breakdown of academic impact, for papers by Bin Sun Breakdown of academic impact, for papers by Timothy Craig Allen Breakdown of academic impact, for papers by Diana N. Ionescu Breakdown of academic impact, for papers by Rosana Eisenberg Breakdown of academic impact, for papers by Daniela Terracciano Breakdown of academic impact, for papers by David Chang Breakdown of academic impact, for papers by Ali S. Alzahrani Breakdown of academic impact, for papers by Wenjian Yang
Rankless by CCL
2026